Please use a PC Browser to access Register-Tadawul
Get It
EXCLUSIVE: Adial Pharmaceuticals Signs Exclusive AD04 Agreement With Molteni Farmaceutici For Europe; Deal Anticipates Nearly $60M Potential Royalties, Milestones
Adial Pharmaceuticals, Inc. ADIL | 1.83 | -7.11% |
